Skip to main content

Table 3 Distribution of survival outcomes in populations with different features

From: Prognostic models for breast cancer: based on logistics regression and Hybrid Bayesian Network

Characteristics

Outcome

p value

Survival

N = 29,230(%)

Dead

N = 29,230(%)

Age (year)

61.0 [51.0;70.0]

60.0 [51.0;66.0]

<0.001***

Tumor Size (mm)

17.0 [10.0;28.0]

23.0 [15.0;36.0]

0.000***

Radiation

  

<0.001***

Beam radiation

18,072 (61.8%)

14,449 (49.4%)

 

Radioactive implants

432 (1.48%)

451 (1.54%)

 

Others

10,726 (36.7%)

14,330 (49.0%)

 

Surg

  

0.000***

No

2119 (7.25%)

9845 (33.7%)

 

Yes

27,111 (92.8%)

19,385 (66.3%)

 

Chemotherapy

  

0.000***

No

18,207 (62.3%)

13,326 (45.6%)

 

Yes

11,023 (37.7%)

15,904 (54.4%)

 

Mets

  

0.000***

No distant metastasis

27,891 (95.4%)

18,461 (63.2%)

 

No evidence of distant mets

43 (0.15%)

47 (0.16%)

 

Distant lymph node(s)

129 (0.44%)

759 (2.60%)

 

Others

1167 (3.99%)

9963 (34.1%)

 

Subtype

  

0.000***

HR-/HER2-

2856 (9.77%)

5186 (17.7%)

 

HR-/HER2+

1119 (3.83%)

1575 (5.39%)

 

HR+/HER2-

22,302 (76.3%)

17,406 (59.5%)

 

HR+/HER2+

2953 (10.1%)

5063 (17.3%)

 

Stage

  

0.000***

1 A

16,899 (57.8%)

10,961 (37.5%)

 

1B

4841 (16.6%)

3438 (11.8%)

 

2 A

2849 (9.75%)

1962 (6.71%)

 

2B

1446 (4.95%)

1012 (3.46%)

 

3 A

792 (2.71%)

448 (1.53%)

 

3B

727 (2.49%)

436 (1.49%)

 

3 C

380 (1.30%)

291 (1.00%)

 

4

1296 (4.43%)

10,682 (36.5%)

 

ER

  

<0.001***

Negative

4283 (14.7%)

7759 (26.5%)

 

Positive

24,947 (85.3%)

21,471 (73.5%)

 

PR

  

<0.001***

Negative

7288 (24.9%)

10,934 (37.4%)

 

Positive

21,942 (75.1%)

18,296 (62.6%)

 

Histologic

  

0.000***

8500

24,910 (85.2%)

20,488 (70.1%)

 

8507

97 (0.33%)

370 (1.27%)

 

8520 or 8521

2992 (10.2%)

4080 (14.0%)

 

8522

1041 (3.56%)

2777 (9.50%)

 

8523 or 8524

135 (0.46%)

219 (0.75%)

 

8530

31 (0.11%)

1238 (4.24%)

 

Others

24 (0.08%)

58 (0.20%)

 

Grade

  

0.000***

1

6392 (21.9%)

4349 (14.9%)

 

2

10,701 (36.6%)

7738 (26.5%)

 

3

5282 (18.1%)

4281 (14.6%)

 

4

6855 (23.5%)

12,862 (44.0%)

 

Site

  

0.000***

C501

1309 (4.48%)

1727 (5.91%)

 

C502

3985 (13.6%)

2916 (9.98%)

 

C503

1629 (5.57%)

1226 (4.19%)

 

C504

10,291 (35.2%)

10,142 (34.7%)

 

C505

2398 (8.20%)

1420 (4.86%)

 

C508

6938 (23.7%)

6190 (21.2%)

 

C509

2680 (9.17%)

5609 (19.2%)

 

Race

  

0.000***

White

22,030 (75.4%)

17,832 (61.0%)

 

Black

2719 (9.30%)

6324 (21.6%)

 

Others

4481 (15.3%)

5074 (17.4%)

 

Marital

  

0.000***

Married

18,114 (62.0%)

14,102 (48.2%)

 

Divorced

3115 (10.7%)

3195 (10.9%)

 

Separated

209 (0.72%)

664 (2.27%)

 

Single

4428 (15.1%)

8093 (27.7%)

 

Unmarried or Domestic Partner

302 (1.03%)

340 (1.16%)

 

Widowed

3062 (10.5%)

2836 (9.70%)

 

Laterality

  

<0.001***

Left - origin of primary

14,886 (50.9%)

13,596 (46.5%)

 

Right - origin of primary

14,344 (49.1%)

15,634 (53.5%)

 

Node

  

\(<\)0.001***

0

6995 (23.9%)

5838 (20.0%)

 

1

13,616 (46.6%)

8923 (30.5%)

 

2

1056 (3.6%)

710 (2.4%)

 

3

1967 (6.7%)

5946 (20.3%)

 

4

4418 (15.1)

4123 (14.1%)

 

5

204 (0.7%)

119 (0.4%)

 

6

112 (0.4%)

136 (0.5%)

 

7

199 (0.7%)

921 (3.2%)

 

8

14 (0.0%)

30 (0.1%)

 

9

160 (0.5%)

174 (0.6%)

 

10

162 (0.6%)

757 (2.6%)

 

11

156 (0.5%)

1083 (3.7%)

 

12

171 (0.6%)

470 (1.6%)

 
  1. *means P \(\le\) 0.05; **means P \(\le\) 0.01; ***means P \(\le\) 0.001
  2. Surg, Primary Site Surgery; Nodes, Lymph Node; Mets, Distant Metastasis; ER, Estrogen Receptor; PR, Progesterone Receptor; Histologic, Histologic Type; Site, Primary Site